🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Aimee Wilkin

Wake Forest University

ORCID: 0000-0003-2435-4738
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen in antiretroviral treatment (ART)-naïve and -experienced, virologically-suppressed adults living with HIV-1.

13 citations

Heather J. Ribaudo, Jorge Leon-Cruz, Edgar T. Overton, Markella V. Zanni, Carlos Malvestutto +89 more

0 citations

Michelle Floris-Moore, Aimee Wilkin, Joseph J. Eron, Angela D. M. Kashuba, Owen Francis +5 more

150 citations

Romain Palich, Jade Ghosn, Sharon Walmsley, Davide Moschese, Claudia P. Cortés +37 more

3 citations

Aya Awwad, Gerald S. Bloomfield, Isabelle R. Weir, Heather J. Ribaudo, Markella V. Zanni +18 more